# Dan Zabrowski

> Dan Zabrowski is a startup investor at Decheng Capital (Shanghai). See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Decheng Capital](https://shizune.co/investors/profile/decheng-capital)
- Location: Shanghai, China
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/dan-zabrowski-b7900a12

Dan Zabrowski is a startup investor at Decheng Capital in Shanghai. Dr. Dan Zabrowski is a Venture Partner at Decheng Capital and has been with the firm since July 2016. Prior to joining Decheng, Dr. Zabrowski worked over 20 years for Roche in a number of key global leadership positions, including Global Head of Regulatory Affairs, Global Head of Development Operations, Global Head of Roche Pharma Partnering,President of Ventana Medical Systems and President of the Roche Sequencing Unit. During his tenure in Business Development and Diagnostics, Dr. Zabrowski and his teams delivered 300+ acquisition and partnership deals. In addition, he was Board member of Chugai Pharmaceuticals. Prior to joining Roche, Dr. Zabrowski worked at Syntex, Fujisawa (now Astellas) and G.D. Searle in their pharmaceutical R&D organizations and served as Adjunct Assistant Professor at the School of Pharmacy, University of Illinois — Chicago. Dr. Zabrowski received his PhD in Organic Chemistry from Indiana University, Bloomington and his BA degree in Chemistry from Saint Louis University.

## About Decheng Capital

VC Fund · Menlo Park, United States

Decheng Capital is an investment firm that provides capital and strategic support to life science companies with revolutionary technologies and growth-stage healthcare companies with a strong market presence. It is a group of dedicated professionals with complementary expertise who have outstanding track records of building highly successfulcompanies globally. Founded in 2012, Decheng continues to capitalize on a historic opportunity in the rapid growth of the healthcare industry as well as breakthroughs in life science research. With over $2 billion in capital under management and support from some of the most prestigious LPs in the world, Decheng is poised to deliver superior returns for our investors and create value for our entrepreneur partners.

5 contacts available at Decheng Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Dan Zabrowski | Venture Partner | https://shizune.co/investors/profile/dan-zabrowski |
| Min Cui | Founder and Managing Director | https://shizune.co/investors/profile/min-cui |
| Dayton Misfeldt | Partner | https://shizune.co/investors/profile/dayton-misfeldt |
| Nathan Pliam | Partner | https://shizune.co/investors/profile/nathan-pliam |
| Victor Tong | Partner | https://shizune.co/investors/profile/victor-tong |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co